Allogene Therapeutics, Inc.
ALLO
$1.23
-$0.065-5.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 280.04M | 292.48M | 291.56M | 444.63M | 384.86M |
| Total Receivables | 2.30M | 1.90M | 2.80M | 2.00M | 1.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.23M | 9.01M | 10.05M | 10.50M | 8.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 291.58M | 303.39M | 304.42M | 457.12M | 395.36M |
|
|
|||||
| Total Current Assets | 291.58M | 303.39M | 304.42M | 457.12M | 395.36M |
| Net Property, Plant & Equipment | 127.07M | 131.26M | 135.30M | 150.47M | 160.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 33.83M | 33.39M | 37.58M | 38.16M | 15.45M |
| Total Assets | 507.98M | 548.71M | 589.12M | 646.88M | 586.35M |
|
|
|||||
| Total Accounts Payable | 5.06M | 5.39M | 5.51M | 12.94M | 5.78M |
| Total Accrued Expenses | 17.33M | 21.55M | 19.68M | 17.15M | 18.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.63M | 7.51M | 7.39M | 7.22M | 6.93M |
| Total Finance Division Other Current Liabilities | -- | 1.07M | -- | -- | 86.00K |
| Total Other Current Liabilities | -- | 1.07M | -- | -- | 86.00K |
| Total Current Liabilities | 30.02M | 35.52M | 32.57M | 37.31M | 30.89M |
|
|
|||||
| Total Current Liabilities | 30.02M | 35.52M | 32.57M | 37.31M | 30.89M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 81.29M | 83.25M | 85.14M | 86.99M | 88.92M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.28M | 7.76M | 7.67M | 7.55M | 5.17M |
| Total Liabilities | 122.59M | 126.53M | 125.37M | 131.85M | 124.98M |
|
|
|||||
| Common Stock & APIC | 2.26B | 2.24B | 2.22B | 2.21B | 2.09B |
| Retained Earnings | -1.88B | -1.82B | -1.76B | -1.69B | -1.63B |
| Treasury Stock & Other | 43.00K | -89.00K | 157.00K | -780.00K | -927.00K |
| Total Common Equity | 385.39M | 422.18M | 463.75M | 515.04M | 461.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 385.39M | 422.18M | 463.75M | 515.04M | 461.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 385.39M | 422.18M | 463.75M | 515.04M | 461.37M |
|
|
|||||